Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

por Richter, Trevor, Janoudi, Ghayath, Amegatse, William, Nester-Parr, Sandra
Publicado 2018

Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review

por Janoudi, Ghayath, Amegatse, William, McIntosh, Brendan, Sehgal, Chander, Richter, Trevor
Publicado 2016